Guidelines for good practice of carbapenems

被引:12
作者
Gauzit, R. [2 ]
Gutmann, L. [3 ]
Brun-Buisson, C. [1 ]
Jarlier, V. [4 ]
Fantin, B. [5 ]
机构
[1] Hop Henri Mondor, AP HP, Serv Reanimat Med, F-94000 Creteil, France
[2] Hop Hotel Dieu, Serv Reanimat Chirurg, AP HP, F-75004 Paris, France
[3] Hop Europeen Georges Pompidou, Serv Bacteriol Virol Hyg, AP HP, F-75015 Paris, France
[4] Hop La Pitie Salpetriere, Serv Bacteriol Virol Hyg, AP HP, F-75013 Paris, France
[5] Hop Beaujon, Serv Med Interne, AP HP, F-92110 Clichy, France
来源
ANTIBIOTIQUES | 2010年 / 12卷 / 04期
关键词
Guidelines; Antimicrobial resistance; Carbapenems; Beta-lactamases; RESISTANT PSEUDOMONAS-AERUGINOSA; VENTILATOR-ASSOCIATED PNEUMONIA; ACQUISITION; ANTIBIOTICS; MULTICENTER; DORIPENEM; EFFICACY; IMIPENEM; ADULTS;
D O I
10.1016/j.antib.2010.09.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Carbapenems are being increasingly used because of the widespread dissemination of antibiotic resistance among Gram-negative bacilli, especially of extended-spectrum beta-lactamases; this increasing use raises the concern of loss of activity for this antimicrobial class following the emergence of carbapenemases. The current guideline from the Anti-infective drugs Committee of the Assistance publique-Hopitaux de Paris (AP-HP) group emphasizes the careful and limited use of carbapenems, comparing the respective characteristics of the four available molecules, and specifies their indications in clinical hospital practice, with possible alternatives. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:183 / 189
页数:7
相关论文
共 50 条
  • [31] The New ESC Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes: the Good and the Not So Good
    Ferrari, Roberto
    Pavasini, Rita
    Censi, Stefano
    Squeri, Angelo
    Rosano, Giuseppe
    CURRENT PROBLEMS IN CARDIOLOGY, 2021, 46 (03)
  • [32] Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis
    Maranchick, Nicole F. F.
    Alshaer, Mohammad H. H.
    Smith, Alison G. C.
    Avaliani, Teona
    Gujabidze, Mariam
    Bakuradze, Tinatin
    Sabanadze, Shorena
    Avaliani, Zaza
    Kipiani, Maia
    Peloquin, Charles A. A.
    Kempker, Russell R. R.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [33] PENICILLINS, MONOBACTAMS, AND CARBAPENEMS
    BODEY, GP
    TEXAS HEART INSTITUTE JOURNAL, 1990, 17 (04) : 315 - 329
  • [34] A New Mechanism for β-Lactamases: Class D Enzymes Degrade 1β-Methyl Carbapenems through Lactone Formation
    Lohans, Christopher T.
    van Groesen, Emma
    Kumar, Kiran
    Tooke, Catherine L.
    Spencer, James
    Paton, Robert S.
    Brem, Jurgen
    Schofield, Christopher J.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2018, 57 (05) : 1282 - 1285
  • [35] Recent developments in carbapenems
    Bonfiglio, G
    Russo, G
    Nicoletti, G
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (04) : 529 - 544
  • [36] Better guidelines for better care: enhancing the implementability of clinical practice guidelines
    Kastner, Monika
    Estey, Elizabeth
    Bhattacharyya, Onil
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (03) : 315 - 324
  • [37] Good practice for conducting and reporting MEG research
    Gross, Joachim
    Baillet, Sylvain
    Barnes, Gareth R.
    Henson, Richard N.
    Hillebrand, Arjan
    Jensen, Ole
    Jerbi, Karim
    Litvak, Vladimir
    Maess, Burkhard
    Oostenveld, Robert
    Parkkonen, Lauri
    Taylor, Jason R.
    van Wassenhove, Virginie
    Wibral, Michael
    Schoffelen, Jan-Mathijs
    NEUROIMAGE, 2013, 65 : 349 - 363
  • [38] Autism spectrum disorder: Practice guidelines for pharmacists
    Kadi, Ryma
    Gayed, Fady
    Kauzman, Patrick
    Amam Ali, Zohal
    Dmitriev, Iliya
    Mikhael, Vanessa
    Ghabi, Rawane
    Hamamji, Jessica
    Jabbour, Sandra
    Mrchak, Monique
    Guirguis, Natalie
    Metras, Marie-Elaine
    Becciolini, Laurent
    Vassel, Faye-Marie
    Gutzeit, Andreas
    Cresson, Jeanne
    Froehlich, Johannes M.
    Higgs, Tamsin
    Dufour, Marie-Michele
    Matoori, Simon
    CANADIAN PHARMACISTS JOURNAL, 2024, 157 (02) : 58 - 65
  • [39] Carbapenems: a potent class of antibiotics
    Nicolau, David P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (01) : 23 - 37
  • [40] Carbapenems in the USA: focus on doripenem
    Lister, Philip D.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2007, 5 (05) : 793 - 809